Solifenacin succinate treatment + Oxycodone and acetaminophen combination treatment
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Flank Pain
Conditions
Flank Pain, Urinary Bladder, Overactive
Trial Timeline
Oct 1, 2010 → Jun 1, 2012
NCT ID
NCT01381120About Solifenacin succinate treatment + Oxycodone and acetaminophen combination treatment
Solifenacin succinate treatment + Oxycodone and acetaminophen combination treatment is a approved stage product being developed by Astellas Pharma for Flank Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01381120. Target conditions include Flank Pain, Urinary Bladder, Overactive.
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01381120 | Approved | Completed |